Univest
Univest
  • Markets

PGIM India Healthcare Fund Analyst Review: NAV, Returns and Key Insights 2026

  • May 28, 2026
  • Posted by: Kashish Aggarwal
  • Category: News
No Comments
PGIM India Healthcare Fund Analyst Review

With a 1-year return of 13.71%, the PGIM India Healthcare Fund has delivered modest gains for investors navigating the current market environment. Managing Rs 92.44 crore in assets at a NAV of Rs 11.03, the fund offers focused exposure to its target category. This review examines key data points and what investors should know before allocating capital in 2026.

Click Here – Get Mutual Fund Advisory

Table of Contents

Toggle
  • What Is the PGIM India Healthcare Fund?
  • PGIM India Healthcare Fund NAV and AUM
  • PGIM India Healthcare Fund Returns: Performance Snapshot
  • Expense Ratio and Cost Efficiency
  • Who Should Invest in PGIM India Healthcare Fund?
  • Key Risks to Consider
  • Conclusion
  • Frequently Asked Questions
    • What is the current NAV of PGIM India Healthcare Fund?
    • What are the returns of PGIM India Healthcare Fund?
    • What is the expense ratio of PGIM India Healthcare Fund Direct Growth?
    • Is this fund suitable for conservative investors?
    • What is the minimum SIP amount for this fund?
    • What category and sub-category does this fund belong to?

What Is the PGIM India Healthcare Fund?

The PGIM India Healthcare Fund is classified as a Sectoral/Thematic equity fund, investing in companies aligned with a specific sector or economic theme. The concentrated nature of such funds can drive strong outperformance when the underlying theme is in favour but can also amplify losses during sector downturns. The fund carries a Very High risk rating and should be treated as a tactical allocation rather than a core holding.

PGIM India Healthcare Fund NAV and AUM

The current NAV of the PGIM India Healthcare Fund Direct Growth plan is Rs 11.03. NAV is updated each trading day and reflects the closing market prices of the fund’s underlying securities. Always verify the most recent NAV on the AMC website or a registered mutual fund platform before placing any transaction.

With an AUM of Rs 92.44 crore, the fund is relatively nimble. This can be advantageous for portfolio agility and the ability to take positions without significant market impact. Investors should track AUM trends alongside performance metrics when evaluating this fund.

PGIM India Healthcare Fund Returns: Performance Snapshot

Period Returns
1 Month 8.14%
3 Months 6.47%
1 Year 13.71%
3 Years (Annualised) Not Available
5 Years (Annualised) Not Available

Return generation has been subdued for the PGIM India Healthcare Fund with a 1-year return of 13.71% and a 3-month figure of 6.47%. Investors already holding this fund should assess whether the underlying investment thesis remains intact. Those considering a new entry should evaluate the fundamental outlook and wait for a clearer performance trend before making a commitment.

Expense Ratio and Cost Efficiency

At 0.75% per annum, the expense ratio of the PGIM India Healthcare Fund Direct Growth plan is moderate for its peer group. The direct plan remains more cost-efficient than the regular variant. Investors should factor the total cost of ownership into their long-term return calculations and compare across category peers before making a final decision.

Who Should Invest in PGIM India Healthcare Fund?

Investors confident in the long-term prospects of the PGIM India Healthcare Fund’s underlying investment theme can consider allocating to this fund as part of a satellite strategy. A minimum 5 to 7-year horizon and Very High risk tolerance are essential. The minimum SIP is Rs 1000 and minimum lumpsum is Rs 5000. Conservative and first-time investors should avoid this fund entirely.

Key Risks to Consider

Timing Risk: Entry at peak valuations during a theme’s popularity can result in extended periods of underperformance. Thematic funds are highly sensitive to investor entry and exit timing.

Regulatory Risk: Sectors such as defence, pharma, and energy can be significantly impacted by government policy changes or regulatory shifts that are difficult to predict in advance.

Theme Obsolescence: Investment themes may lose relevance due to technological disruption, changing consumer behaviour, or structural shifts in the underlying industry.

Market Volatility: Equity-linked funds can experience sharp short-term NAV corrections during periods of broad market sell-offs, sector-specific adverse events, or macro-level uncertainty.

Download the Univest iOS App or Univest Android App to track this fund’s live NAV and manage your portfolio.

Conclusion

The PGIM India Healthcare Fund has delivered modest returns in a challenging environment, but its expense ratio of 0.75% and AUM of Rs 92.44 crore reflect a cost-efficient and investor-supported structure. Those already holding this fund should review the underlying investment thesis. New investors should ensure they have a sufficient horizon before committing capital. Consult a SEBI-registered investment advisor before any allocation change.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Frequently Asked Questions

What is the current NAV of PGIM India Healthcare Fund?

Ans. The current NAV of the PGIM India Healthcare Fund Direct Growth plan is Rs 11.03. NAV is updated each trading day and reflects the closing market value of the fund’s underlying holdings. Always verify the most recent NAV on the AMC website or a SEBI-registered mutual fund platform before transacting.

What are the returns of PGIM India Healthcare Fund?

Ans. The fund has delivered a 1-year return of 13.71% and a 3-month return of 6.47%. The 3-year annualised return is Not Available and the 5-year annualised return is Not Available. Past performance does not guarantee future results and should be evaluated alongside the fund’s risk profile and benchmark comparison.

What is the expense ratio of PGIM India Healthcare Fund Direct Growth?

Ans. The expense ratio of the PGIM India Healthcare Fund Direct Growth plan is 0.75% per annum. The direct plan eliminates distributor commissions and is more cost-efficient than the regular plan. Investors should always opt for the direct plan to maximise long-term net returns through the compounding advantage of lower costs.

Is this fund suitable for conservative investors?

Ans. No. This fund carries a Very High risk rating due to concentrated exposure to a specific market segment or investment theme. It is not suitable for conservative investors or those with short investment timelines. A minimum 5 to 7-year horizon and a high risk tolerance are required prerequisites. Consult a SEBI-registered investment advisor before investing.

What is the minimum SIP amount for this fund?

Ans. The minimum monthly SIP is Rs 1000 and the minimum lumpsum investment is Rs 5000. The low entry thresholds make the fund accessible across income levels. A regular SIP approach is recommended to average out entry costs over time, particularly given the high-volatility nature of this fund’s category.

What category and sub-category does this fund belong to?

Ans. This fund is a Sectoral/Thematic equity fund with a focused portfolio aligned to a specific sector or theme. It falls under the Sectoral / Thematic sub-category and is available as a direct growth plan, which eliminates distributor commissions and typically offers superior net returns compared to the regular plan.



Author: Kashish Aggarwal
Kashish Aggarwal is a Financial Content Writer at Univest, covering Indian equity markets with a focus on share price target frameworks, technical analysis education, and sector deep-dives. Her published work spans bull-case/bear-case share price analysis, event-driven stock reactions, and beginner-friendly educational guides. Her articles blend fundamental analysis (analyst consensus targets, P/E, loan book quality, margin dynamics) with technical analysis (moving averages, 200-DMA, support/resistance levels) — giving retail investors a complete framework before any position. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards. Coverage Areas • Share price targets — REC Ltd, Adani Green Energy (bull/bear case frameworks) • Event-driven analysis — Redington (US tariff impact), Star Cement (technical breakdown) • Technical analysis education — Direct Market Access, 200-DMA, indicator interpretation • Thematic listicles — Highest Dividend Paying Stocks, Real Estate Penny Stocks, Intraday Picks • Sector coverage — IT distribution, renewable energy, infrastructure finance, cement, real estate

Leave a Reply Cancel reply